A. Rider
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Bone health and treatments
- PARP inhibition in cancer therapy
-
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
Papers in
- Oncology 30
- Bone health and treatments 11
-
- Advanced Breast Cancer Therapies 14
- Prostate Cancer Treatment and Research 5
- Co-authors
- Adam Roughley (4 shared papers)Gavin Taylor‐Stokes (2 shared papers)Shrividya Iyer (1 shared paper)Zev Sthoeger (1 shared paper)Zvi Bentwich (1 shared paper)David Geltner (1 shared paper)Roger von Moos (8 shared papers)Katie Lewis (24 shared papers)
- Journals
- Annals of Oncology (16 papers)Value in Health (11 papers)Journal of Clinical Oncology (7 papers)Future Oncology (5 papers)Cancer Research (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
A. Rider
67 papers receiving 526 citations
Peers
Comparison fields: 5 of 61
- Oncology 209
- Pulmonary and Respiratory Medicine 108
- Hematology 37
- Rheumatology 47
- Otorhinolaryngology 10
Countries citing papers authored by A. Rider
This map shows the geographic impact of A. Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rider more than expected).
Fields of papers citing papers by A. Rider
This network shows the impact of papers produced by A. Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rider. The network helps show where A. Rider may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Rider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 165 | |
| 2 | Systemic lupus erythematosus in 49 Israeli males: a retrospective study. | 1988 | 48 |
| 3 | 2013 | 30 | |
| 4 | 2018 | 28 | |
| 5 | 2017 | 26 | |
| 6 | 2014 | 22 | |
| 7 | 2021 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2019 | 15 | |
| 10 | 2019 | 14 | |
| 11 | 2020 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2019 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2017 | 4 |
About A. Rider
A. Rider is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Hematology, having authored 71 papers that have together received 535 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (14 papers), Advanced Breast Cancer Therapies (14 papers), Bone health and treatments (11 papers), Economic and Financial Impacts of Cancer (6 papers), Acute Myeloid Leukemia Research (6 papers), Breast Cancer Treatment Studies (5 papers), Prostate Cancer Treatment and Research (5 papers) and Nutrition, Genetics, and Disease (5 papers). The work is most often cited by research in Oncology (209 citations), Pulmonary and Respiratory Medicine (108 citations), Hematology (37 citations), Rheumatology (47 citations) and Otorhinolaryngology (10 citations). A. Rider has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Adam Roughley, Gavin Taylor‐Stokes, Shrividya Iyer, Zev Sthoeger, Zvi Bentwich, David Geltner, Roger von Moos, Katie Lewis, Guy Hechmati and Francesca Gatta. Their work appears in journals such as Annals of Oncology, Value in Health, Journal of Clinical Oncology, Future Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.